16,039
回編集
「ケタミン」の版間の差分
ナビゲーションに移動
検索に移動
細
編集の要約なし
細編集の要約なし |
細編集の要約なし |
||
| 49行目: | 49行目: | ||
| onset = | | onset = | ||
* Intravenous: seconds<ref name="sinner" /> | * Intravenous: seconds<ref name="sinner" /> | ||
* Intramuscular: 1–5 min<ref name="sinner" /><ref name="Quibell2011"> | * Intramuscular: 1–5 min<ref name="sinner" /><ref name="Quibell2011">{{cite journal |last1= Quibell |first1= R |last2= Prommer |first2= EE |last3= Mihalyo |first3= M |last4= Twycross |first4= R |last5= Wilcock |first5= A |displayauthors= 4 |title= Ketamine* |journal= [[Journal of Pain and Symptom Management]] |date= March 2011 |volume= 41 |issue= 3 |pages= 640–9 |doi= 10.1016/j.jpainsymman.2011.01.001 |pmid= 21419322 |url= http://www.jpsmjournal.com/article/S0885-3924%2811%2900046-7/fulltext |type= Therapeutic Review|doi-access= free }}</ref> | ||
* Subcutaneous: 15–30 min<ref name="Quibell2011" | * Subcutaneous: 15–30 min<ref name="Quibell2011" /> | ||
* Insufflation: 5–10 min<ref name="sinner" /> | * Insufflation: 5–10 min<ref name="sinner" /> | ||
* By mouth: 15–30 min<ref name="sinner" /><ref name="Quibell2011" /> | * By mouth: 15–30 min<ref name="sinner" /><ref name="Quibell2011" /> | ||